New algorithm more accurately predicts life expectancy after heart failure

May 17, 2018

A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more personalized assessments of people who are awaiting heart transplants, which in turn could enable health care providers to make better use of limited life-saving resources and potentially reduce health care costs.

As precision medicine gains ground in health care, this study could be a key step toward tailoring organ transplant procedures to individual patients. The study, which was published in PLOS One, was led by Mihaela van der Schaar, Chancellor's Professor of Electrical and Computer Engineering at the UCLA Samueli School of Engineering.

The algorithm, which the researchers call Trees of Predictors, uses machine learning -- meaning that computers effectively "learn" from additional new data over time. It takes into account 53 data points -- including age, gender, body mass index, blood type and blood chemistry -- to address the complex differences among people waiting for heart transplants and the compatibility between potential heart transplant recipients and donors.

Trees of Predictors uses these 53 data points to predict how long people with heart failure will live, based on whether they receive a transplant or not. (Of those data points, 33 relate to information about the recipients or potential recipients, 14 pertain to the donors and six apply to the compatibility between donor and recipient.)

The researchers tested the Trees of Predictors on 30 years of data on people who were registered with the United Network for Organ Sharing, the nonprofit organization that matches donors and transplant recipients in the U.S. They found that their algorithm provided significantly better predictions for how long someone would live for than the current methods that health care providers use.

It also outperformed predictions from machine learning methods that have been developed by other research groups.

"Our work suggests that more lives could be saved with the application of this new machine-learning-based algorithm," said van der Schaar, who also is a Turing Fellow at the Alan Turing Institute in London, and the Man Professor at University of Oxford. "It would be especially useful for determining which patients need heart transplants most urgently and which patients are good candidates for bridge therapies such as implanted mechanical-assist devices."

The algorithm is able to analyze many possible risk scenarios for potential transplant candidates to help doctors more thoroughly assess people who could be candidates for heart transplants, and it is flexible enough to incorporate more data as treatments evolve.

"Following this method, we are able to identify a significant number of patients who are good transplant candidates but were not identified as such by traditional approaches," said Dr. Martin Cadeiras, a cardiologist at the David Geffen School of Medicine at UCLA. "This methodology better resembles the human thinking process by allowing multiple alternative solutions for the same problem but taking into consideration the variability of each individual."

For example, when compared against prediction models that most doctors currently use to project which transplant recipients would live for at least three years after a transplant, a commonly used benchmark, the UCLA algorithm outperformed the models by 14 percent -- correctly predicting that 2,442 more heart transplant recipients of the 17,441 who received transplants and lived at least that long after the surgery.
-end-
In addition to van der Schaar and Cadeiras, the study's other primary authors are Jinsung Yoon, a UCLA engineering doctoral student, and William Zame, a UCLA distinguished professor of economics and mathematics. Contributing authors are Dr. Amitava Banerjee of the Farr Institute of Health Informatics Research at University College London, and Ahmed Alaa, a UCLA engineering doctoral student.

Van der Schaar said that the Trees of Predictors algorithm could be used for insights from medical databases and many other types of complex databases. Already, Yoon, Zame and van der Schaar have shown it can work to recognize handwriting, and to predict credit card fraud and the popularity of specific news items.

The study was supported by the National Science Foundation and the Office of Naval Research.

UCLA Henry Samueli School of Engineering of Applied Science

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.